Vertaling van "evidence from a meta-epidemiologic study " (Nederlands → Frans) :

L, et al. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
L, et al. Single-center trials show larger treatment effects than multicenter trials: evidence from a metaepidemiologic study.

Table 7: Evidence form systematic reviews and meta analysis (breast cancer mortality reduction in intervention group) Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence
Table 9: Evidence form systematic reviews and meta analysis (breast cancer mortality reduction in intervention group) Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence

In June 2002, concerned with the recrudescence of MRSA in Belgium, the GDEPIH-GOSPIZ and the Health Council proposed to revise the national guidelines and update the recommended policies with evidence from studies published in the last decade and dealing with the local epidemiological situation.
2 Evolution de la révision des recommandations en 2003 En juin 2002, s’inquiétant de la recrudescence de MRSA en Belgique, le GDEPIH-GOSPIZ et le Conseil supérieur d’Hygiène ont proposé de revoir les recommandations nationales et de mettre à jour les politiques conseillées à l’aide des résultats des études publiées au cours des dix dernières années, tout en se concentrant sur la situation épidémiologique locale.

Table 8: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Relative risks (intention to treat) with confidence reported for each study together with the results of a stepwise meta-analysis and cumulative CI Study ID Relative risk Confidence interval Cumulative RR Cumutlative CI UK Age Trial (UK) 0,83 (0,66-1,04) 0,83 (0,66-1,04) NBSS-1 (Canada) 0,97 (0,74-1,27) 0,89 (0,75-1,06) Malmö (Sweden) (0,58-1,77) 0,9 (0,76-1,06) Stockholm (Sweden) 1,08 (0,54-2,17) 0,91 (0,77-1,07) Göteborg (Sweden) 0,65 (0,40-1,05) 0,87 (0,75-1,02) HIP (USA) 0,75 (0,50-1,11) 0,86 (0,74-0,99) TCS (Sweden) 0,93 (0,63-1,36) 0,86 (0,75-0,99) Edinburgh (UK) 0,75 (0.48-1,18) 0,85 (0,75-0,97)
Table 10: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Relative risks (intention to treat) with confidence reported for each study together with the results of a stepwise meta-analysis and cumulative CI Study ID Relative risk Confidence interval Cumulative RR Cumutlative CI UK Age Trial (UK) 0,83 (0,66-1,04) 0,83 (0,66-1,04) NBSS-1 (Canada) 0,97 (0,74-1,27) 0,89 (0,75-1,06) Malmö (Sweden) (0,58-1,77) 0,9 (0,76-1,06) Stockholm (Sweden) 1,08 (0,54-2,17) 0,91 (0,77-1,07) Göteborg (Sweden) 0,65 (0,40-1,05) 0,87 (0,75-1,02) HIP (USA) 0,75 (0,50-1,11) 0,86 (0,74-0,99) TCS (Sweden) 0,93 (0,63-1,36) 0,86 (0,75-0,99) Edinburgh (UK) 0,75 (0.48-1,18) 0,85 (0,75-0,97)

[Can J Psychiatry 2007; 52:248-55 met bespreking in Evid Based Ment Health 2007; 10:115] In deze meta-analyse werden slechts 5 gerandomiseerde gecontroleerde studies geïncludeerd (n=165), zodat de resultaten met enige voorzichtigheid dienen geïnterpreteerd te worden.
[Can J Psychiatry 2007; 52:248-55 avec une discussion dans Evid Based Ment Health 2007; 10:115] Cette méta-analyse n’a inclus que 5 études randomisées contrôlées (n=165), de sorte que les résultats doivent être interprétés avec prudence.

Tabel 1: Daling van de specifieke sterfte bij vrouwen van 40 tot 49 jaar Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence
Table 1: Réduction de la mortalité spécifique Study ID Ref Population Intervention Results of

individual data on 53 297 women with breast cancer and 100 239 without breast cancer from 54 epidemiological studies. Lancet
collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 without breast cancer from 54

- Job A., Raynal M., Tricoire A., Signoret J., Rondet P. 2000. Hearing status of French youth aged from 18 to 24 years in 1997: a cross-sectional epidemiological study in the selection centres of the army in Vincennes and Lyon.
- Job A., Raynal M., Tricoire A., Signoret J., Rondet P. Hearing status of French youth aged from 18 to 24 years in 1997: a cross-sectional epidemiological study in the selection